A multi-modal EHR-based approach to screen patients for oncology clinical trials.

Authors: Afghahi, Anosheh, Frahm, Filip, Kaur, Maneet, Lu, Yichen, Cipolla, Catharine Kline, Leybovich, Barry, Altomare, Ivy, Meropol, Neal J.

Source: Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p411-411, 13p

Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.

Authors: Kaur, Maneet, Frahm, Filip, Lu, Yichen, Ascha, Mustafa S., Guadamuz, Jenny S., Dotan, Efrat, Gottesman, Adam S., Leybovich, Barry C., Sondhi, Arjun, Zhao, Yihua, Meropol, Neal J., Royce, Trevor J.

Source: NEJM Evidence; Apr2024, Vol. 3 Issue 4, p1-11, 11p

Subject Terms: DIVERSITY & inclusion policies, CLINICAL trials, LOGISTIC regression analysis, CANCER patients, RETROSPECTIVE studies, DESCRIPTIVE statistics, ODDS ratio, ELIGIBILITY (Social aspects), MEDICAL records, ACQUISITION of data, ELECTRONIC health records, TUMORS, CONFIDENCE intervals, SOCIAL classes, PROPORTIONAL hazards models, OVERALL survival

Trial eligibility criteria (EC) and diversity among patients with advanced non small cell lung cancer (advNSCLC).

Authors: Kaur, Maneet, Frahm, Filip, Ascha, Mustafa, Guadamuz, Jenny, Gottesman, Adam, Leybovich, Barry, Sondhi, Arjun, Zhao, Yihua, Meropol, Neal J., Royce, Trevor Joseph

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p1566-1566, 1p